“Achievement of No-to-minimal Itch and Sleep Improvement with Tapinarof Cream 1% Once Daily in Two Pivotal Phase 3 Trials in Adults and Children Down to 2 Years of Age with Atopic Dermatitis”, J of Skin, vol. 8, no. 6, p. s459, Nov. 2024, doi: 10.25251/skin.8.supp.459.